Condition

Other Solid Tumors clinical trials and research

• 7Clinical trials
• 1New in 30 days
• 4Countries

Newest Other Solid Tumors clinical trials

All recruiting trials (7)

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• NCI CCDI registry for very rare pediatric and young adult solid tumors

  This registry collects medical records and tumor genetic data from children, teens, and young adults (1 month–39 years) newly diagnosed with very rare solid tumors to help researchers learn more and guide future treatments.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07489378

• DXC008 treatment for prostate cancer and other solid tumors

  This phase 1 trial will test whether DXC008 is safe and shows early anti-cancer activity in adults with prostate cancer or other advanced solid tumors who have exhausted standard therapies.

  Recruiting at 4 sites Phase 1 Hangzhou DAC Biotechnology Co., Ltd. · Changsha, Hunan and 3 other locations · NCT06926283

• KRAS neoantigen mRNA vaccine for patients with KRAS-mutated solid tumors

  This study is testing a new mRNA vaccine for patients with advanced solid tumors that have KRAS mutations to see if it can help them when used alone or with another treatment.

  Recruiting Early Phase 1 Ruijin Hospital · Shanghai · NCT06577532

• Treatment with engineered T cells for advanced solid tumors with a specific mutation

  This study is testing a new T cell therapy for patients with advanced solid tumors that have a specific mutation to see if it can help fight their cancer.

  Recruiting at 16 sites Phase 1 AstraZeneca · Gilbert, Arizona and 19 other locations · NCT05877599

• Testing BL-M07D1 for advanced digestive tract and solid tumors

  This study is testing a new treatment called BL-M07D1 to see if it is safe and effective for people with advanced digestive tract and solid tumors.

  Recruiting Phase 1 Sichuan Baili Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT05631964

• Evaluating IDE196 for patients with specific solid tumors

  This study is testing a new treatment called IDE196 for people with specific solid tumors that have certain genetic changes to see if it can help shrink their tumors and how safe it is.

  Recruiting at 7 sites Phase 1/2 IDEAYA Biosciences · Los Angeles, California and 14 other locations · NCT03947385

Related topics

Quick answers

How many Other Solid Tumors clinical trials are recruiting right now?

7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (4 trials), United States (3 trials), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →